23
Views
3
CrossRef citations to date
0
Altmetric
Research Article

99mTc-sestaMIBI Scintigraphy in Thalidomide-treated Refractory or Relapsed Multiple Myeloma Patients

, , , , &
Pages 1081-1082 | Published online: 01 Jul 2009

  • Barlogie, B., Zangari, M., Spencer, T., et al. (2001) "Thalidomide in the management of multiple myeloma", Seminars in Hematology 38, 250 - 259
  • Fonti, R., Del Vecchio, S., Zanetti, A., et al. (2001) "Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma", European Journal of Nuclear Medicine 28, 214 - 220
  • Wakasugi, S., Teshima, H., Nakamura, H., et al. (1998) "Tc-99m MIBI localization in bone marrow: a marker of bone marrow malignancy", Clinical Nuclear Medicine 23, 664 - 671
  • Pace, L., Catalano, L., Pinto, A., et al. (1998) "Different patterns of technetium-99m sestamibi uptake in multiple myeloma", European Journal of Nuclear Medicine 25, 714 - 720
  • Catalano, L., Pace, L., Califano, C., et al. (1999) "Detection of focal myeloma lesions by technetium-99m sestamibi scintigraphy", Haematologica 84, 119 - 124
  • Svaldi, M., Tappa, C., Gebert, U., et al. (2001) "Technetium-99m-sestamibi scintigraphy: an alternative approach for diagnosis and follow-up of active lesions after high dose chemotherapy and autologous stem cell transplantation", Annals of Hematology 80, 393 - 397

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.